T7 High Yield RNA Synthesis Kit for Co-transcription (low dsRNA, with cap1 analog)

SKU:BHT20800007
Research Validated
Overview
Click light‑blue chips for details
The kit utilizes T7 RNA Polymerase (Low dsRNA) and high-affinity LZcap AG Cap1 analog to produce mRNAs with significantly reduced double-stranded RNA (dsRNA) content and enhanced expression. Single-stranded RNAs are synthesized using linear double-stranded DNA containing a T7 promoter sequence as th
Kit Category Process / Workflow Kits
Grade RUO
Storage -20°C
Shipping Dry Ice
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size (2) - 50 T, 100 T
  • Lead time: options listed in “Availability Content”; otherwise, there will be a column of “lead time”, other statuses may take longer.
  • Storage: -20°C
  • Shipping: cold-chain shipment (typically with ice packs).
  • Upon receipt: store at the recommended temperature as soon as possible.
  • Sales terms and conditions: Please review prior to ordering.
Options selector
Catalog no. Size
10635ES50 50 T
10635ES60 100 T
Field Specification
Product Type
  • RNA Synthesis Kit
Shipping Dry Ice
Storage -20°C

Description

The kit utilizes T7 RNA Polymerase (Low dsRNA) and high-affinity LZcap AG Cap1 analog to produce mRNAs with significantly reduced double-stranded RNA (dsRNA) content and enhanced expression. Single-stranded RNAs are synthesized using linear double-stranded DNA containing a T7 promoter sequence as the template. Modified nucleotides, such as biotin or dye-labeled nucleotides, can be incorporated during transcription to generate labeled RNA. The kit supports the synthesis of both long and short transcripts, yielding 100–200 μg of RNA from 1 μg of DNA template. Substituting UTP with N1-Me-Pseudo UTP reduces RNA immunogenicity. The resulting RNA is suitable for downstream applications, including RNA structure and function studies, RNase protection, probe hybridization, RNAi, microinjection, and in vitro translation.

Components

Components No.

Name

10635ES10

(10 T)

10635ES50 (50 T)

10635ES60

(100 T)

10635ES70

(500 T)

10635-A

T7 RNA Polymerase Mix

20 μL

100 μL

200 μL

1 mL

10635-B

10×Transcription Buffer

20 μL

100 μL

200 μL

1 mL

10635-C

ATP100mM

20 μL

100 μL

200 μL

1 mL

10635-D

CTP100mM

20 μL

100 μL

200 μL

1 mL

10635-E

GTP100mM

20 μL

100 μL

200 μL

1 mL

10635-F

N1-Me-Pseudo UTP100mM

20 μL

100 μL

200 μL

1 mL

10635-G

Control DNA Template500ng/μL

5 μL

10 μL

20 μL

100 μL

10635-H

DNase I (2 U/μL)

10 μL

50 μL

100 μL

500 μL

10635-I

Cap1 Analog (100 mM)

20 μL

100 μL

200 μL

1 mL

10635-J

Lithium chloride solution

300 μL

1.5 mL

3 mL

15 mL

10635-K

RNase-free ddH2O

500 μL

2.5 mL

5 mL

25 mL

Note: The T7 RNA Polymerase Mix includes T7 RNA polymerase (Low dsRNA, Cat: 10628), Murine RNase inhibitor (Cat: 10621) and Pyrophosphatase Inorganic (Cat: 10620); The Cap1 Analog is LZcap AG (Cat: 10684). The catalog number of recommended UTP and Pseudo UTP is 10654 and 10656, respectively.   

Features

  • Complete Kit Components: Includes all essential reagents for one-step co-transcriptional capping, such as NTPs, T7 Enzyme Mix, cap analog, DNase I, and LiCl.
  • Simplified Workflow: Utilizes a co-transcriptional capping process, minimizing the number of components introduced and streamlining the overall procedure for ease of use.
  • High Yield: Generates 150–200 µg of Cap 1 mRNA from just 1 µg of DNA template.
  • Reduced Immunogenicity: Incorporates modified N1-Me-pUTP and a low dsRNA T7 RNA polymerase to minimize unintended innate immune responses.
  • High Capping Efficiency: Achieves capping efficiency exceeding 99%.

Figure

1. Broad Applicability:  

Consistently delivers a high yield of 9 mg/mL with capping efficiency up to 100% in a 20 µL reaction system using 1 µg of plasmid DNA, regardless of the length of the target transcript.

mRNA Category

Yield(mg/mL)

mRNA Integrity(%)

Capping Efficiency(%)

eGFP

11.2

93.5

100%

OVA

10.2

94.3

100%

mcherry

9.1

90.3

100%

Luciferase

9.3

90.1

100%

Cas 9

9

88.7

100%

Table 1. Broad applicability of the Co-transcription system

 

Cap analog

Cap Concn. (mM)

Yields (mg/mL)

Integrity (%)

Capping efficiency by MS (%)

1

Cap AG    (3'OMe-7mG)

10

12.69

80.6

100

2

LZCap AG

10

12.11

82.8

100

3

LZCap AG

7.5

11.59

82.2

100

4

LZCap AG

5

11.16

81.6

100

5

LZCap AG

2.5

10.75

81.4

100

Figure 1. Co-transcription analysis of the input of LZcap AG. IVT materials include Hieff™ T7 RNA Polymerase, Template: Cas9 (4K); T7 Reaction Buffer 2; Tris NTP (including N1-Me-Pseudo UTP Tris Solution).  IVT time: 3 hrs.

Figure 1. Co-transcription analysis of the input of LZcap AG. IVT materials include Hieff™ T7 RNA Polymerase, Template: Cas9 (4K); T7 Reaction Buffer 2; Tris NTP (including N1-Me-Pseudo UTP Tris Solution).  IVT time: 3 hrs.

Fragment Length

T7 RNA pol

Yield (mg/mL)

 Integrity (%)

dsRNA Content (ng/ug of RNA)

4K mRNA

Regular T7 Kit

12.4

88.3

0.4273

Low dsRNA T7 Kit

12.1

89.9

0.0129

9K mRNA

Regular T7 Kit

9.5

81.9

2.9180

Low dsRNA T7 Kit

9.0

82.0

0.0379

 

Table 2. dsRNA content analysis of regular T7 Kit and Low dsRNA T7 Kit.

Storage

This product should be stored at -25 ~-15℃ for one year.

Notes:

1. Be careful not to mix RNase in the reaction system.

2. Experiment equipment (such as: pipette tip, product tube, etc.) should strictly use RNase-free products.

3. For your safety and health, please wear lab coats and disposable gloves.

4. For research use only!

Document

Safety Data Sheet

10635_MSDS

Manual

10635_Manual_EN20250703.pdf

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Supplier Ads Slides show

Add dynamic ads with slider